Last reviewed · How we verify
NCT04170075
Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy
NA trial testing Whole Body Vibration in Chemotherapy-Induced Peripheral Neuropathy in 38 participants. Completed in 9 December 2022.
9 December 2022
Quick facts
| Lead sponsor | OHSU Knight Cancer Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 38 |
| Start date | 5 August 2019 |
| Primary completion | 9 December 2022 |
| Estimated completion | 9 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Whole Body Vibration
Conditions studied
- Chemotherapy-Induced Peripheral Neuropathy — all drugs for Chemotherapy-Induced Peripheral Neuropathy →
- Hematopoietic and Lymphoid Cell Neoplasm — all drugs for Hematopoietic and Lymphoid Cell Neoplasm →
- Malignant Solid Neoplasm — all drugs for Malignant Solid Neoplasm →
Sponsor
OHSU Knight Cancer Institute
Who can join
18 and older, any sex, with Chemotherapy-Induced Peripheral Neuropathy or Hematopoietic and Lymphoid Cell Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial studies how well whole body vibration works in improving the health and functioning of participants with chemotherapy-induced peripheral neuropathy. Peripheral neuropathy is a condition caused by exposure to chemotherapy drugs that may involve numbness/tingling and/or pain in the hands and feet, which can have adverse effects on daily life. Whole body vibration may cause weight loss and improve mobility and pain levels in cancer survivors who report symptoms of peripheral neuropathy.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Resistance training for fatigue in people with cancer.
Ernst M, Wagner C, Oeser A, Messer S, et al · · 2024 · cited 3× · PMID 39606939 · DOI 10.1002/14651858.cd015518 -
Low-Intensity Vibration to Reduce Symptoms and Improve Physical Functioning in Cancer Survivors With Chemotherapy-Induced Peripheral Neuropathy: A Pilot Randomized Trial.
Krasnow SM, Rubin CT, Roeland EJ, Horak FB, et al · · 2026 · PMID 40373263 · DOI 10.1200/op-24-00961
Verify or expand the search:
- PubMed search for NCT04170075
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Whole Body Vibration
Trials testing the same drug.
- NCT07253467 — Load Dependent Modulation of Spinal Excitability: Linking H-Reflex Supression and Whole Body Vibration Induced Reflex La · NA · completed
- NCT07002125 — Whole Body Vibration Therapy in Individuals With Type 2 Diabetes · NA · recruiting
- NCT06691737 — Effect of Whole-body Vibration on Postural Stability, Muscle Flexibility and Lower Limb Power in Young Basketball Player · NA · not yet recruiting
- NCT06407921 — Whole Body Vibration and BOSU Ball in Spastic Cerebral Palsy · NA · completed
- NCT06829680 — Investigation of the Effects of Pilates Training Combined with Whole Body Vibration on Balance and Mobility in Individua · NA · completed
Other recruiting trials for Chemotherapy-Induced Peripheral Neuropathy
Currently open trials in the same condition.
- NCT07365007 — A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Ca · NA · recruiting
- NCT06731894 — Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors · Phase 2 · recruiting
- NCT07164950 — Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patien · NA · recruiting
- NCT06945380 — Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced · NA · recruiting
- NCT05368428 — Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III E · NA · recruiting
Other OHSU Knight Cancer Institute trials
Trials by the same sponsor.
- NCT05453851 — A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatme · Phase 1, PHASE2 · not yet recruiting
- NCT07511504 — Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanc · Phase 2 · not yet recruiting
- NCT07434128 — Mammogram Pretreatment With Ulipristal Acetate · Phase 2 · not yet recruiting
- NCT07504835 — GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer · NA · not yet recruiting
- NCT07498517 — Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04170075 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by OHSU Knight Cancer Institute
- Last refreshed: 30 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04170075.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing